ADVERSE DRUG REACTIONS

Slides:



Advertisements
Similar presentations
Warfarin, Insulin and Digoxin are the most Dangerous drugs in the elderly. Do we believe that?
Advertisements

The management of adverse drug reactions I Ralph Edwards
Introduction Medication non adherence ( noncompliance) remains a major problem. You have to assess and treat adherence related problems that can adversely.
Horng H Chen MD on behalf of the NHLBI Heart Failure Clinical Research Network Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF):
Principles of Drug Use in the Elderly Alastair Stephens Sophie Rozwadowski.
SUA
{ ADVERSE DRUG REACTIONS To ensure patient, family/caregiver and home health personnel are instructed to identify adverse reactions to medications and.
Outcomes Personal Pharmacist ™ Training Module/Encounter™ MTM Case Examples.
Introduction to Pharmacology. Overview Pharmaceutics Pharmacokinetics Pharmacodynamics.
An ABC of Drug-Related Problems RHB Meyboom, M Lindquist, ACG Egberts Drug Safety 2000;22:
Heart Failure James Masters. Rough outline Introduction overview Allocation of teams 5 minutes for signs and symptoms 5 minutes for investigations and.
Yasar Kucukardali Professor, Internal Medicine Yeditepe University.
CHAPTER 24: Converging Issues in Heart Disease, Stroke, and Alzheimer’s Disease in Women.
Asthma Management Fine Tuning  Maximum control with minimum medication  Start with mild asthma and work up the scale (BTS/SIGN 2004)
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 11 Drug Therapy in Geriatric Patients.
Clinical causality assessment I. Ralph Edwards R.H.B Meyboom.
VALENCE SOF + RBV Not randomised Open label* ≥ 18 years Chronic HCV infection Genotype 2 or 3 HCV RNA ≥ 10,000 IU/ml Treatment naïve or prior IFN-based.
Basics of outpatient depression management Chris Zamani MD.
Primary Care Trigger Tool Manaia Health PHO Linda Holman Quality Leader.
ADVERSE EFFECTS OF DRUGS Phase II May Adverse Drug Reaction An adverse reaction to a drug is a harmful or unintended response. ADRs are claimed.
PHARMACOVIGILANCE AND CLINICAL TRIALS DIVISION 20 August 2015 Victoria Falls Protecting Your Right to Quality Medicines and Medical Devices.
Background Collection of S & O Information Data: – CC, HPI, PMH, PSHx, Demographics – Medication history including compliance etc. – VS, ROS, Lab, other.
Hemophilia U & I Inc., USA Payor Education Presentation Last Updated; January, 2012.
Introduction to Pharmacology PHARM TECH. Pharmacology  Pharmacology is the science that deals with the study of therapeutic (beneficial) agents.  Knowledge.
BHIVA Clinical Audit Management of patients who switch therapy; re-audit of patients starting therapy from naïve.
Anri Uys (MSc Pharmacology, BPharm NWU) Medicines Information Centre, Division of Clinical Pharmacology University of Cape Town.
Problems of Polypharmacy
BHIVA Clinical Audit Management of patients who switch therapy; re-audit of patients starting therapy from naïve.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 2 Application of Pharmacology in Nursing Practice.
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
1 Xavier University of Louisiana College of Pharmacy Curriculum Map – NAPLEX Competencies Map by Competency.
METHODS TO STUDY DRUG SAFETY PROBLEMS animal experiments clinical trials epidemiological methods –spontaneous reporting case reports case series –Post-Marketing.
ALI R. RAHIMI, BOBBY WRIGHTS, MD, HOSSEIN AKHONDI, MD & CHRISTIAN M. RICHARD, MSC Clinical Correlation Between Effective Anticoagulants & Risk of Stroke:
Tuberculosis care and control in refugee and displaced population: An interagency field manual 2 nd edition © World Health Organization 2007 Edited by.
CRITICAL APPRAISAL OF ARTICLE ON HARM. Among patients with acute rheumatic fever, will discontinuation of penicillin have adverse effects? Clinical question.
Adverse Reaction Tracking (ART) Basics May Course Objectives Upon completion of this session the student will: Understand the need for a comprehensive.
Within the same individual VARIATION IN DRUG RESONSIVNESS Between different individuals Decrease in drug effects. Development of side effects Decrease.
Bledsoe et al., Paramedic Care Principles & Practice Volume 1: Introduction © 2006 by Pearson Education, Inc. Upper Saddle River, NJ Basic Pharmacology.
Introduction to Pharmacology. ORIENTATION TO PHARMACOLOGY Objectives: 1. Definition of the four basic terms (drug, pharmacology, clinical pharmacology,
Quality Education for a Healthier Scotland Pharmacy Pharmaceutical Care Planning Vocational Training Scheme: Level = Stage 2 Arlene Shaw Specialist Clinical.
Drug Therapy in the Elderly
Patient’s Medication Experience 1. Notes One of the important variables that if succeed it will affect in providing good pharmaceutical care. It is an.
TOLERANCE, DESENSITIZATION & ADVERSE DRUG REACTIONS
INTRODUCTION CLINICAL PHARMACOKINETICS
Signal identification and development I.Ralph Edwards.
1 Adherence to ARV Therapy and Resistance HAIVN Havard Medical School AIDS Initiative in Vietnam.
Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Introduction to Pharmacology Yacoub Irshaid MD, PhD, ABCP Department of Pharmacology.
CLASSIFICATION, MECHANISMS, CLINICAL MANIFESTATIONS.
1 Recent Advances in Provision of Primary Care in the Public Sector: Is 3 Days of Oral Antibiotic Therapy Enough for Treatment of Ambulatory Pneumonia?
How and Why Drugs Work Chapter 5. Intended and Unintended Effects of Drugs Intended responses: - Reason for using the drug Unintended responses: - Side.
Department of Pharmacy, Ditmanson Medical Foundation Chia-Yi Christian Hospital Suspect Moxifloxacin Induced Torsades de Pointes: A case report Ya-Wen.
HELICOBACTER PYLORI Millions of years old microorganism of mankind Causes a spectrum of diseases Obviously requires high priority Treatment strategies.
Sayed Ali Mus POST GRADUATES-BATCH 6 FACULTY OF MEDICAL LABORATORY SCIENCES PARASITOLOGY DEPARTMENT ALNEELIN UNIVERSITY March 2015 Symposium on: Advances.
ANTICOAGULATION The objectives of this section are: To be able to write prescriptions according to local anticoagulation guidelines To know how to prescribe.
TOLERANCE, DESENSITIZATION & ADVERSE DRUG REACTIONS
Integrative Approaches to Pharmacotherapy—A Look at Complex Cases
SHARON CHAN1, SARAH DENMAN1 & SINISA SAVIC1*
Factors Affecting Drug Activity
DRUG PRESCRIBING.
Compliance & Non-Compliance
Gout Management.
Pharmacovigilance (PV)
Figure 19.1 Alzheimer disease and the resulting dementia occur when changes in the brain hamper neurotransmission.
Module 18 Pain Management Revised.
Application of Pharmacology in Nursing Practice
Individual Variation in Drug Responses
PROSES TERAPI DAN PERMASALAHANNYA
Tramadol Induced Vomiting
Tapering and Discontinuing Chronic Opioid Therapy
Presentation transcript:

ADVERSE DRUG REACTIONS Dr. Rita Grace Y. Alvero

Adverse Drug Reactions Introduction

Adverse Drug Reactions Definition any response to a drug that is noxious and unintended and that occurs at doses of an appropriately given drug used in man for prophylaxis, diagnosis or therapy

Adverse Drug Reactions Significance adverse - beneficial significant - insignificant apparent - hidden severity acute - chronic

Adverse Drug Reactions Incidence 30% - 1 or > ADR 3% severe reaction 0.3% die 5% - OP basis extremes of age ♀ > ♂ 28% past Hx

Factors Affecting ADR Patient Related age sex genetic influences concurrent diseases compliance with dosing regimen total number of medications previous ADRs misc. (diet, smoking, environment)

Factors Affecting ADR Drug Related doses, duration inherent toxicity pharmacokinetics pharmacodynamics

Types of ADR Type A (Augmented) Type B (Bizzare) Type C (Continuous) Type D (Delayed) Type E (Ending of Use) Type F (Failure of treatment)

Type A 2 types – extension side effect

Type B no formal response curve very small doses can elicit the reaction immunological

Type C continuous, long term dose and duration of therapy

Type D longer period of time carcinogenesis, teratogenecity, immunotoxicity

Type E withdrawal reactions

Type F substandard presence of toxic excipients antimicrobial resistance tolerance

Recognizing ADRs Has this drug ever caused this type of reaction as reported in the lit? Is the timing of the patient’s response to the drug typical of previous reports? Can other likely reasons or causes for the patient’s syndrome be eliminated? Has the patient ever had a similar response to this drug? If the drug is discontinued, does the patient improve? If the drug is restarted, does the syndrome recur?

Scoring 10 – 12 - likely ADR 7 – 9 - probable ADR 4 – 6 - possible ADR 0 – 3 - unlikely ADR

Management of AD

Points to Remember to Reduce Occurrence of ADR Critically review the total cond of the patient Use as few drugs as possible Know well the drugs that you use Do not change from 1 drug to another Do not hesitate to use textbooks and other references Be very careful when prescribing drugs known to exhibit a large variety of reactions / interactions

Points to Remember to Reduce Occurrence of ADR Be aware of interactions Regularly make an inventory of the drugs your patient is receiving If your patient shows sign and symptom not clearly explained by the course of illness, think of ADR

75 year old female Dx: HPN (BP – 170/105) Tx: Nifedipine 20 mg BID Follow - up 1 mo later (1st ff-up) 1 mo later (2nd ff-up) 2 wks later (3rd ff-up) 1 mo later (4th ff-up) BP 120/70 BP controlled BP controlled BP 180/100 Problems dizziness dyspepsia swollen ankles gout swollen ankles hypokalemia Nifedipine Furosemide K supplements Diclofenac 50 mg TID + Allopurinol Tx Nifedipine 20 mg BID Furosemide 2.5 mg OD Ranitidine 150 mg BID Nifedipine Furosemide 5 mg OD K supplement 2 tab BID